Analysts predict that athenahealth, Inc. (NASDAQ:ATHN) will report $0.07 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Twelve analysts have made estimates for athenahealth’s earnings, with estimates ranging from $0.03 to $0.11. athenahealth posted earnings of $0.06 per share in the same quarter last year, which suggests a positive year-over-year growth rate of 16.7%. The business is scheduled to issue its next quarterly earnings results on Thursday, July 20th.

According to Zacks, analysts expect that athenahealth will report full year earnings of $0.84 per share for the current year, with EPS estimates ranging from $0.75 to $0.89. For the next financial year, analysts expect that the firm will post earnings of $1.09 per share, with EPS estimates ranging from $0.90 to $1.25. Zacks’ earnings per share calculations are an average based on a survey of research firms that follow athenahealth.

athenahealth (NASDAQ:ATHN) last announced its quarterly earnings data on Thursday, April 27th. The health services provider reported $0.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.11 by $0.01. athenahealth had a net margin of 1.84% and a return on equity of 5.93%. The company had revenue of $285.40 million for the quarter, compared to analysts’ expectations of $296.49 million. During the same period last year, the business earned $0.34 earnings per share. The company’s quarterly revenue was up 11.4% compared to the same quarter last year.

Several brokerages recently commented on ATHN. Stifel Nicolaus reiterated a “hold” rating and set a $151.00 price target (up from $106.00) on shares of athenahealth in a research report on Friday. Cantor Fitzgerald cut athenahealth from an “overweight” rating to a “neutral” rating and set a $140.00 price target for the company. in a research report on Tuesday, June 13th. Citigroup Inc. reiterated a “buy” rating and set a $163.00 price target (up from $128.00) on shares of athenahealth in a research report on Monday, June 5th. Robert W. Baird upped their target price on athenahealth from $140.00 to $160.00 and gave the company an “outperform” rating in a report on Thursday, May 25th. Finally, Dougherty & Co upped their target price on athenahealth from $123.00 to $148.00 and gave the company a “buy” rating in a report on Tuesday, May 23rd. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $138.74.

Shares of athenahealth (NASDAQ ATHN) traded up 0.54% during midday trading on Monday, reaching $146.14. 477,648 shares of the company’s stock were exchanged. The company’s 50-day moving average is $124.44 and its 200-day moving average is $115.88. The stock has a market cap of $5.82 billion, a P/E ratio of 287.68 and a beta of 1.81. athenahealth has a one year low of $90.11 and a one year high of $146.75.

TRADEMARK VIOLATION NOTICE: This piece was originally published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another publication, it was illegally stolen and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2017/06/19/0-07-eps-expected-for-athenahealth-inc-athn-this-quarter-2.html.

In related news, SVP Jonathan D. Porter sold 300 shares of athenahealth stock in a transaction on Monday, May 15th. The stock was sold at an average price of $109.48, for a total transaction of $32,844.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Jonathan Bush sold 8,000 shares of athenahealth stock in a transaction on Tuesday, April 25th. The stock was sold at an average price of $120.00, for a total value of $960,000.00. Following the transaction, the chief executive officer now directly owns 319,807 shares of the company’s stock, valued at $38,376,840. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 20,283 shares of company stock valued at $2,569,523. 3.20% of the stock is currently owned by insiders.

A number of institutional investors have recently modified their holdings of ATHN. Clearbridge Investments LLC boosted its position in athenahealth by 61.8% in the first quarter. Clearbridge Investments LLC now owns 908,505 shares of the health services provider’s stock worth $102,379,000 after buying an additional 347,133 shares during the period. FNY Partners Fund LP boosted its position in athenahealth by 1,900.0% in the first quarter. FNY Partners Fund LP now owns 1,000 shares of the health services provider’s stock worth $112,000 after buying an additional 950 shares during the period. Credit Suisse AG boosted its position in athenahealth by 404.5% in the first quarter. Credit Suisse AG now owns 300,420 shares of the health services provider’s stock worth $33,854,000 after buying an additional 240,876 shares during the period. Tudor Investment Corp ET AL boosted its position in athenahealth by 85.3% in the first quarter. Tudor Investment Corp ET AL now owns 7,604 shares of the health services provider’s stock worth $857,000 after buying an additional 3,501 shares during the period. Finally, Nomura Holdings Inc. boosted its position in athenahealth by 176.6% in the first quarter. Nomura Holdings Inc. now owns 7,212 shares of the health services provider’s stock worth $812,000 after buying an additional 4,605 shares during the period.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Get a free copy of the Zacks research report on athenahealth (ATHN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.